Intracellular signaling in the neuro-immune axis
The role of adrenoceptor-mediated signals in the modulation of lymphocyte function

https://doi.org/10.1016/0960-5428(95)00019-XGet rights and content

Abstract

Adrenoceptors are heterotrimeric glycoproteins that bind specific endogenous ligands, such as the sympathetic neurotransmitter norepinephrine and the neurohormone epinephrine. Ligand binding to an adrenoceptor expressed on the cell surface initiates a cascade of biochemical and molecular responses inside the cell that lead to a change in cellular activity. Initially, the stimulation of an adrenoceptor directly activates G proteins that stimulate enzymes to induce the production of second messengers. The cascade continues as the second messengers activate serine/threonine protein kinases, resulting in either an inhibition or enhancement of cellular activity. The resulting changes in cellular activity are mediated by changes in gene expression that are induced by the phosphorylation of specific transcription factors.

Adrenoceptor subtypes are expressed by both T and B lymphocytes. The aim of this review is to summarize and discuss the results from the many studies that have examined the role of adrenoceptor-mediated intracellular signals in the modulation of lymphocyte function. Another aim of this review is to discuss how these studies have advanced our understanding of the mechanisms by which the sympathetic nervous system transmits information to both T and B lymphocytes to maintain immune homeostasis.

References (112)

  • M.M. Khan et al.

    Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes

    Biol. Psychiat.

    (1986)
  • W. Krawietz et al.

    Different numbers of beta-receptors in human lymphocyte subpopulations

    Biochem. Pharmac.

    (1982)
  • B.E. Loveland et al.

    The detection of beta-adrenoceptors on murine lymphocytes

    Int. J. Immunopharmac.

    (1981)
  • G.J.M. Maestroni et al.

    Noradrenergic modulation of lymphohematopoiesis

    Int. J. Immunopharmac.

    (1994)
  • G.J.M. Maestroni et al.

    Effect of adrenergic agents on hematopoiesis after syngeneic bone marrow transplantation in mice

    Blood

    (1992)
  • H. Meurs et al.

    Characterization of (-)-[3H]Dihydroalprenolol binding to intact and broken cell preparations of human peripheral blood lymphocytes

    Eur. J. Pharmac.

    (1982)
  • D.J. Park et al.

    Inhibition of CD3-linked phospholipase C by phorbol ester and by cAMP is associated with decreased phosphotyrosine and increased phosphoserine contents of PLC-γ1

    J. Biol. Chem.

    (1992)
  • R. Pochet et al.

    Betaadrenoceptors display different efficiency on lymphocyte subpopulations

    Biochem. Pharmac.

    (1983)
  • T.L. Roszman et al.

    Neurotransmitters and molecular signaling in the immune response

  • R.R. Ruffolo et al.

    Alpha-adrenoceptors

    Pharmac. Ther.

    (1994)
  • S. Titinchi et al.

    Alpha-2-adrenoceptors in human lymphocytes: direct characterization by [3H]yohimbine binding

    Biochem. Biophys. Res. Commun.

    (1984)
  • M.A. Alava et al.

    Increased intracellular cyclic AMP inhibits inositol phospholipid hydrolysis induced by perturbation of the T cell receptor/CD3 complex but not by G-protein stimulation

    Biochem. J.

    (1992)
  • P. Andre et al.

    Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class II (Ia) molecules

    J. Exp. Med.

    (1994)
  • R.J. Armitage et al.

    Molecular and biological characterization of a murine ligand for CD40

    Nature

    (1992)
  • M. Betz et al.

    Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines

    J. Immunol.

    (1991)
  • H.K. Blomhoff et al.

    Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes

    J. Cell. Physiol.

    (1987)
  • W.H. Boom et al.

    Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4-and interleukin 2-producing T cell clones on resting B lymphocytes

    J. Exp. Med.

    (1988)
  • H.R. Bourne et al.

    Adenyl cyclase in human leukocytes: evidence for activation by separate beta adrenergic and prostaglandin receptors

    J. Pharmacol. Exp. Ther.

    (1971)
  • J.C. Cambier et al.

    Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes

    Nature

    (1987)
  • E.K. Chartash et al.

    Direct human T helper cell-mediated B cell activation is not mediated by inositol lipid hydrolysis

    J. Immunol.

    (1988)
  • D. Chen et al.

    Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles

    J. Exp. Med.

    (1994)
  • Z.Z. Chen et al.

    Transmembrane signaling through B cell MHC class II molecules: anti-Ia antibodies induce protein kinase C translocation to the nuclear fraction

    J. Immunol.

    (1987)
  • M.E. Conolly et al.

    The beta-adrenoceptor of the human lymphocyte and human lung parenchyma

    Br. J. Pharmacol.

    (1977)
  • R.H. DeKruyff et al.

    Induction of antigen-specific antibody responses in primed and unprimed B cells

    Functional heterogeneity among Th1 and Th2 clones

    J. Immunol.

    (1989)
  • D. Dennig et al.

    Interleukin-2 may enhance or inhibit antibody production by B cells depending on intracellular cAMP concentrations

    Immunology

    (1992)
  • F.R. DeRubertis et al.

    Role of cyclic adenosine 3′,5′-monophosphate in lymphocyte mitogenesis

    J. Immunol.

    (1974)
  • T. Diamantstein et al.

    The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes

    Immunology

    (1975)
  • L. Elliott et al.

    Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination

    Cell. Molec. Neurobiol.

    (1992)
  • G. Estes et al.

    Inhibition of lymphocyte stimulation by cyclic and non-cyclic nucleotides

    J. Immunol.

    (1971)
  • R.D. Feldman et al.

    Beta-adrenergic receptor-mediated suppression of interleukin 2 receptors in human lymphocytes

    J. Immunol.

    (1987)
  • F.D. Finkelman et al.

    Lymphokine control of in vivo immunoglobulin isotype selection

    A. Rev. Immunol.

    (1990)
  • B.A. Fuchs et al.

    Enhancement of the murine primary antibody response by phenylephrine in vitro

    Drug Chem. Toxicol.

    (1991)
  • T.F. Gajewski et al.

    Evidence implicating utilization of different T cell receptor-associated signaling pathways by Th-1 and Th-2 clones

    J. Immunol.

    (1990)
  • J.C. Goin et al.

    Active alpha 2 and beta adrenoceptors in lymphocytes from patients with chronic lymphocytic leukemia

    Int. J. Cancer

    (1991)
  • K.H. Grabstein et al.

    The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2

    J. Immunol.

    (1993)
  • P. Hasler et al.

    Human T lymphocyte cAMP-dependent protein kinase: subcellular distributions and activity ranges of type I and type II isozymes

    FASEB J.

    (1992)
  • H. Holte et al.

    Cyclic AMP has the ability to influence multiple events during B cell stimulation

    Eur. J. Immunol.

    (1988)
  • D.L. Johnson et al.

    Effect of chronic beta-adrenergic therapy on the human lymphocyte response to concanavalin A

    Res. Commun. Chem. Pathol. Pharmac.

    (1981)
  • D.L. Johnson et al.

    Effects of beta-adrenergic agents on the murine lymphocyte response to mitogen stimulation

    J. Immunopharmac.

    (1981)
  • G.M. Kammer et al.

    Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes

    J. Clin. Invest.

    (1994)
  • Cited by (53)

    • T-lymphocyte tyrosine hydroxylase regulates T<inf>H</inf>17 T-lymphocytes during repeated social defeat stress

      2022, Brain, Behavior, and Immunity
      Citation Excerpt :

      The loss of TH within T-lymphocytes would result in deficient production of all catecholamines, which canonically bind adrenergic receptors to influence T-lymphocyte functionality. There is a breadth of literature which has focused on the intracellular cascade that follows adrenergic receptor (AR) binding (Elkhatib and Case, 2019; Kin and Sanders, 2006; McAlees et al., 2011; Nance and Sanders, 2007; Sanders, 1995), and there are several potential pathways which could explain this relationship. In our work herein, we were able to rescue the attenuated ex vivo production of IL-17A and IL-22 by THT-KO T-lymphocytes through primarily NE supplementation.

    • Dexmedetomidine attenuates pancreatic injury and inflammatory response in mice with pancreatitis by possible reduction of NLRP3 activation and up-regulation of NET expression

      2018, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      On the other hand, NLRP3 is closely related to the innate immune system and inflammation [30]. Molecular mechanisms mediating sympathoimmune interactions have been extensively studied [31–33]. NE released from sympathetic nerve endings binds to α- and/or β-adrenergic receptors expressed on immune cells (T cells, B cells, NK cells, and macrophages).

    • Psychosocial stress and inflammation in cancer

      2013, Brain, Behavior, and Immunity
    • The Blood-Brain Barrier in Psychoneuroimmunology

      2009, Immunology and Allergy Clinics of North America
      Citation Excerpt :

      Adrenergic compounds are perhaps the most significant class of neuroimmune substances excluded by the BBB. Epinephrine and norepinephrine secreted from the adrenal medulla and adrenergic nerves have been shown to affect immune cell functions.3 Adrenergic compounds are excluded by the physical presence of the BBB and also by enzymatic degradation by the brain capillaries.4

    • Restraint stress impairs early wound healing in mice via α-adrenergic but not β-adrenergic receptors

      2007, Brain, Behavior, and Immunity
      Citation Excerpt :

      Norepinephrine and epinephrine activate both α- and β-adrenergic receptors, of which α-adrenergic receptors are the predominantly expressed receptors in the skin (Ahlquist, 1976). Virtually all lymphoid cells express the β-adrenergic receptor with the exception of murine T helper 2 cells (Sanders, 1995). The responses of macrophages and neutrophils, both important players in wound healing, can be altered by adrenergic agonists (Barnes, 1999).

    View all citing articles on Scopus
    View full text